| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8452608 | Experimental Hematology | 2018 | 44 Pages |
Abstract
- Expression of miR-193a and miR-600 is decreased in patients with acute myeloid leukemia (AML).
- MiR-193a and miR-600 synergistically reduce WT1 expression in AML cells.
- WT1 inhibits miR-600 expression by binding the putative pre-miR-600 promoter.
- MiR-193a and miR-600 have anti-leukemia activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Haiying Li, Chongyun Xing, Bin Zhou, Haige Ye, Jianhua Feng, Jianbo Wu, Shenmeng Gao,